Nystatin

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Nystatin
Generic name: NYSTATIN
Manufacturer: Torrent Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 559b5bd4-3564-4437-8d0a-fa3a972f8b83
SPL ID: 96bcc133-c446-4fce-a99a-ccd1039ded49
Version: 9
Effective date: 2026-05-01
Source export date: 2026-10-30
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/023bc8d8aae5addb7530087bbbdb169b3ccbf36764f15b8ca67db07e1e5aea8b/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 19:09:28

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 14 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	212557	derived:openfda.application_number
application number		ANDA212557	openfda.application_number
brand name		Nystatin	openfda.brand_name
generic name		NYSTATIN	openfda.generic_name
manufacturer name		Torrent Pharmaceuticals Limited	openfda.manufacturer_name
ndc	package	13668-595-02	openfda.package_ndc
ndc	package	13668-595-01	openfda.package_ndc
ndc	product	13668-595	openfda.product_ndc
ndc11	package	13668059501	derived:openfda.package_ndc
ndc11	package	13668059502	derived:openfda.package_ndc
rxcui		543546	openfda.rxcui
spl id		96bcc133-c446-4fce-a99a-ccd1039ded49	id
spl set id		559b5bd4-3564-4437-8d0a-fa3a972f8b83	set_id
unii		BDF1O1C72E	openfda.unii

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS The frequency of adverse events reported in patients using nystatin cream is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application. (See PRECAUTIONS: General. )

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.